Adjuvant Global Health Technology Fund, L.P.

Holdings History for AN2 Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 2.37M shares
Security Ownership: 7.9%

Adjuvant Capital GP, L.P. ownership in AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX)

2025-02-28 - Adjuvant Capital GP, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.37M shares of AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX). This represents 7.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Adjuvant Capital GP, L.P.	7.9%		$3.23M	2.37M			$1.36	13G/A	12/31/2024	28 Feb 2025 19:57:57